In the latest trading session, Celgene (CELG) closed at $96.80, marking a -0.32% move from the previous day. This change lagged the S&P 500's 0.06% gain on the day. Meanwhile, the Dow gained 0.16%, ...

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on October 31, Celgene Corp.'s Director, Rodman L Drake, ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Celgene (CELG) or Vertex Pharmaceuticals (VRTX). But which of these two stocks is more ...

. The target price for CELG is set to $64. Jefferies & Co says, “Celgene's Revlimid became eligible for a generic challenge since December 27, 2009, so today's Paragraph IV filing should come as no ...

Forbes contributors publish independent expert analyses and insights. We provide aggregated data on dividend stocks. Nov 24, 2015, 11:12am EST Nov 24, 2015, 11:12am EST This article is more than 10 ...

TheStreet’s Jim Cramer says investors need to see money return to the highest-growth names, which have had a shrinking price-to-earnings multiple, as the market moves from the first quarter into the ...

After years of growth, Celgene Corporation (NASDAQ: CELG) has spent the past eight months suffering from ever-weakening price action. But 'all good things must eventually come to an end.' And for ...

19 April 2004 – Brazilian power distributor Celg said Friday it plans to raise as much as $125m on international markets to finance the expansion of its power supply network, reports Business News ...

Celgene (CELG) closed the most recent trading day at $87.91, moving -0.62% from the previous trading session. This move lagged the S&P 500's daily gain of 0.37%. Elsewhere, the Dow gained 0.25%, while ...